IP Library Granted Patent US 11,426,410
Granted Patent B2
US 11,426,410 · App. 16/551,373 · Granted Aug 30, 2022

Theacrine-based supplement and method of use thereof in a synergistic combination with caffeine

Inventors: Hector L Lopez (Cream Ridge, NJ); Shawn Wells (Lewisville, TX); Tim N. Ziegenfuss (Chardon, OH)
Assignee: Ortho-Nutra, LLC
A61K31/522A23L33/10A23L33/105A61K31/133A61K31/14A61K31/4748A61K31/685A61K31/7048A61K31/7068C07D487/04A23V2002/00
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 11,426,410
App. No.
16/551,373
Granted
Aug 30, 2022
Kind
B2
Abstract

A human dietary supplement comprises theacrine and optionally other compounds that modulate the effects of theacrine. Uses for the theacrine-containing supplement include improvement of at least one of mood, energy, focus, concentration or sexual desire or a reduction of at least one of anxiety or fatigue. A synergistic composition comprises co-administration of theacrine and caffeine, wherein the co-administered caffeine reduces theacrine oral clearance (CL/F) and oral volume of distribution (Vd/F). In addition, the co-administered caffeine increases area under the plasma concentration time curve (AUC) of theacrine, and increases theacrine maximum plasma concentration (C max ) in comparison with the corresponding pharmacokinetic parameters when theacrine is administered alone.

Claims (11)

1. A dietary supplement, comprising:

a nutraceutically acceptable carrier in combination with theacrine caffeine, and methylliberine;

wherein the dietary supplement is formulated for oral administration;

wherein the theacrine is present in the dietary supplement in an amount that modulates activity of the caffeine, wherein said amount of theacrine is from about 5 mg to about 850 mg.

2. The dietary supplement of claim 1 , wherein the theacrine has a purity of at least 95%.

3. The dietary supplement of claim 1 , wherein the theacrine is present in the supplement in an amount of between 65-300 mg.

4. The dietary supplement of claim 1 , wherein the dietary supplement is formulated into a solid oral dosage form.

5. The dietary supplement of claim 1 , wherein the dietary supplement is formulated to, upon oral administration, increase mood, energy, focus, concentration, and/or sexual desire.

6. The dietary supplement of claim 1 , wherein the theacrine is produced synthetically or is isolated from a natural source and purified to at least 50% theacrine.

7. The dietary supplement of claim 4 , wherein said solid oral dosage form is a powder, capsule, or tablet.

8. The dietary supplement of claim 1 , wherein said caffeine is present in an amount of about 25 mg to about 650 mg and in a ratio of about 0.5:1 to about 50:1 by weight caffeine:theacrine.

Assignments (1)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Sep 17, 2019
From: LOPEZ, HECTOR L; WELLS, SHAWN; ZIEGENFUSS, TIM
To: ORTHO-NUTRA, LLC
Reel/Frame 050401/0697 →
Continuity (4)
Continuation 15600371 · May 19, 2017
Continuation In Part 14539726 · Nov 12, 2014
Provisional Application 61903362 · Nov 12, 2013
Related Publication 20190374546A1 · Dec 12, 2019